3P Clinical significance of achieving no evidence of disease in HER2-positive metastatic breast cancer: A multicenter study by Turkish Oncology Group (TOG)

Read full text Summarise with VIRAT
Authors: B. Dursun, S. Yaslikaya, Serhat Sekmek, Tuğba Önder, H.C. Yildirim, O. Acar, N. Sever, Savaş Gökçek, S. Ön, F. Aslan, G.S.Y. Keskin, Zehra Sucuoğlu İşleyen
+8 more Gözde Savaş, Mehmet Kalender, Öznur Bal, Ü Y Arslan, Mustafa Şahbazlar, B. Cakar, H.M. Türk, H. Akbulut
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Achieving no evidence of disease (NED) in HER2-positive metastatic breast cancer (MBC) has been proposed as a surrogate for durable disease control. However, its clinical significance and predictive factors are not yet well established.

Fields of Study & Subjects

HER2/EGFR in Cancer Research Gastric Cancer Management and Outcomes Breast Cancer Treatment Studies

Publication details

Journal / source
ESMO Open
Volume
11
Pages
106106–106106
Publication date
1 April 2026
Language
EN